Antibody-PROTAC Conjugates Enable HER2-Dependent Targeted Protein Degradation of BRD4. (2020)

First Author: Maneiro MA
Attributed to:  Site-selective antibody modification by cysteine-to-lysine transfer (CLT) funded by EPSRC

Abstract

No abstract provided

Bibliographic Information

Digital Object Identifier: http://dx.doi.org/10.1021/acschembio.0c00285

PubMed Identifier: 32338867

Publication URI: http://europepmc.org/abstract/MED/32338867

Type: Journal Article/Review

Volume: 15

Parent Publication: ACS chemical biology

Issue: 6

ISSN: 1554-8929